Partners
Partners

Partner 17 - Oslo University Hospital


Prof. Bjørn Naume, MD, PhD

 

Principal Investigator

 

Phone: +4722934000

undefinedE-Mail

 

 

Oslo University Hospital

 

Postbox 4953 Nydalen

0424 Oslo

Norway

undefinedWebsite

CANCER-ID Team Oslo

Hege Russness, MD, PhD

field of work: ctDNA

 

Phone: +4722934000

undefinedE-Mail

 

 

Elin Borgen, MD, PhD

field of work: CTCs

 

Phone: +4722934000

undefinedE-Mail

 

 

Åslaug Helland, MD, PhD

Associate Professor

field of work: lung cancer studies

 

Phone: +4722934000

undefinedE-Mail

 

Kristine Kleivi, PhD

field of work: miRNA

 

undefinedE-Mail

 

Institute presentation

The group members constitute a strong team for translational breast cancer (BC) research with a well-functioning infrastructure representing the basis for a number of large multicenter prospective translational/clinical studies within breast and lung cancer. The members have close interaction with the clinic and with the national clinical groups. The institute has been active in research related to

  •    isolated tumour cells in bone marrow and blood (detection technologies, standardisation and clinical validation)
  •    molecular biology of breast and lung cancer
  •    exploring the systems biology of breast cancer using high dimensional data in integrated approaches
  •    ctDNA and miRNA in blood, and whole genome sequencing of single cells (DTCs/CTCs).

The principle role in the CANCER-ID project will be to provide valuable clinical samples from blood and primary tumours, cross-testing of technical methods and clinical validation.

CANCER-ID Consortium

CANCER-ID Workpackages

CANCER-ID Work Plan

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

organized by our Partner Menarini SiliconBiosystems Read more

Social Media

LinkedIn Cancer-ID